203 related articles for article (PubMed ID: 30226288)
1. An Update on Patents Covering Agents That Interfere with the Cancer Glycolytic Cascade.
Fortunato S; Bononi G; Granchi C; Minutolo F
ChemMedChem; 2018 Nov; 13(21):2251-2265. PubMed ID: 30226288
[TBL] [Abstract][Full Text] [Related]
2. Glycolysis Inhibitors for Anticancer Therapy: A Review of Recent Patents.
Sheng H; Tang W
Recent Pat Anticancer Drug Discov; 2016; 11(3):297-308. PubMed ID: 27087655
[TBL] [Abstract][Full Text] [Related]
3. An update on therapeutic opportunities offered by cancer glycolytic metabolism.
Granchi C; Fancelli D; Minutolo F
Bioorg Med Chem Lett; 2014 Nov; 24(21):4915-25. PubMed ID: 25288186
[TBL] [Abstract][Full Text] [Related]
4. Targeting Key Transporters in Tumor Glycolysis as a Novel Anticancer Strategy.
Shi Y; Liu S; Ahmad S; Gao Q
Curr Top Med Chem; 2018; 18(6):454-466. PubMed ID: 29788889
[TBL] [Abstract][Full Text] [Related]
5. Cancer cell metabolism: implications for therapeutic targets.
Jang M; Kim SS; Lee J
Exp Mol Med; 2013 Oct; 45(10):e45. PubMed ID: 24091747
[TBL] [Abstract][Full Text] [Related]
6. Modeling cancer glycolysis under hypoglycemia, and the role played by the differential expression of glycolytic isoforms.
Marín-Hernández A; López-Ramírez SY; Del Mazo-Monsalvo I; Gallardo-Pérez JC; Rodríguez-Enríquez S; Moreno-Sánchez R; Saavedra E
FEBS J; 2014 Aug; 281(15):3325-45. PubMed ID: 24912776
[TBL] [Abstract][Full Text] [Related]
7. Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer.
Tilekar K; Upadhyay N; Iancu CV; Pokrovsky V; Choe JY; Ramaa CS
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188457. PubMed ID: 33096154
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer.
Akins NS; Nielson TC; Le HV
Curr Top Med Chem; 2018; 18(6):494-504. PubMed ID: 29788892
[TBL] [Abstract][Full Text] [Related]
9. Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines.
Tyszka-Czochara M; Bukowska-Strakova K; Kocemba-Pilarczyk KA; Majka M
Nutrients; 2018 Jun; 10(7):. PubMed ID: 29958416
[TBL] [Abstract][Full Text] [Related]
10. Natural compounds regulate glycolysis in hypoxic tumor microenvironment.
Gao JL; Chen YG
Biomed Res Int; 2015; 2015():354143. PubMed ID: 25685782
[TBL] [Abstract][Full Text] [Related]
11. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
12. Glycolysis-based drug delivery nanosystems for therapeutic use in tumors and applications.
Geng C; Pang S; Ye R; Shi J; Yang Q; Chen C; Wang W
Biomed Pharmacother; 2023 Sep; 165():115009. PubMed ID: 37343435
[TBL] [Abstract][Full Text] [Related]
13. Targeting glucose metabolism to develop anticancer treatments and therapeutic patents.
Zhou Y; Guo Y; Tam KY
Expert Opin Ther Pat; 2022 Apr; 32(4):441-453. PubMed ID: 35001793
[TBL] [Abstract][Full Text] [Related]
14. Anticancer agents that counteract tumor glycolysis.
Granchi C; Minutolo F
ChemMedChem; 2012 Aug; 7(8):1318-50. PubMed ID: 22684868
[TBL] [Abstract][Full Text] [Related]
15. Glycolytic enzyme inhibitors in cancer treatment.
Scatena R; Bottoni P; Pontoglio A; Mastrototaro L; Giardina B
Expert Opin Investig Drugs; 2008 Oct; 17(10):1533-45. PubMed ID: 18808312
[TBL] [Abstract][Full Text] [Related]
16. Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect.
Chen XS; Li LY; Guan YD; Yang JM; Cheng Y
Acta Pharmacol Sin; 2016 Aug; 37(8):1013-9. PubMed ID: 27374491
[TBL] [Abstract][Full Text] [Related]
17. Regulation of aerobic glycolysis to decelerate tumor proliferation by small molecule inhibitors targeting glucose transporters.
Gao M; Huang J; Jiang X; Yuan Y; Pang H; Luo S; Wang N; Yao C; Lin Z; Pu D; Zhang S; Sun P; Liu Z; Xiao Y; Wang Q; Hu Z; Yin H
Protein Cell; 2020 Jun; 11(6):446-451. PubMed ID: 32410006
[No Abstract] [Full Text] [Related]
18. Possible therapeutic targets among the molecules involved in the Warburg effect in tumor cells.
Nam SO; Yotsumoto F; Miyata K; Shirasu N; Miyamoto S; Kuroki M
Anticancer Res; 2013 Jul; 33(7):2855-60. PubMed ID: 23780970
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of the Warburg effect in gastrointestinal cancer (review).
Sawayama H; Ishimoto T; Sugihara H; Miyanari N; Miyamoto Y; Baba Y; Yoshida N; Baba H
Int J Oncol; 2014 Oct; 45(4):1345-54. PubMed ID: 25070157
[TBL] [Abstract][Full Text] [Related]
20. The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen?
López-Lázaro M
Anticancer Agents Med Chem; 2008 Apr; 8(3):305-12. PubMed ID: 18393789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]